<?xml version='1.0' encoding='utf-8'?>
<document id="28851254"><sentence text="Quantitative prediction of the extent of drug-drug interaction using a physiologically based pharmacokinetic model that includes inhibition of drug metabolism determined in cryopreserved hepatocytes." /><sentence text="1" /><sentence text=" A physiologically based pharmacokinetic (PBPK) model that includes inhibition constant evaluated in cryopreserved hepatocytes was used to predict drug-drug interactions (DDIs) between orally administered nifedipine, a CYP substrate, and fluconazole or ketoconazole, CYP inhibitors, in rats"><entity charOffset="205-215" id="DDI-PubMed.28851254.s3.e0" text="nifedipine" /><entity charOffset="238-249" id="DDI-PubMed.28851254.s3.e1" text="fluconazole" /><entity charOffset="253-265" id="DDI-PubMed.28851254.s3.e2" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.28851254.s3.e0" e2="DDI-PubMed.28851254.s3.e0" /><pair ddi="false" e1="DDI-PubMed.28851254.s3.e0" e2="DDI-PubMed.28851254.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28851254.s3.e0" e2="DDI-PubMed.28851254.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28851254.s3.e1" e2="DDI-PubMed.28851254.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28851254.s3.e1" e2="DDI-PubMed.28851254.s3.e2" /></sentence><sentence text=" 2" /><sentence text=" The Kp,uu, ratio of unbound inhibitor concentration in liver ([I]liver,u) to that in plasma ([I]sys,u), of fluconazole and ketoconazole was 1"><entity charOffset="108-119" id="DDI-PubMed.28851254.s5.e0" text="fluconazole" /><entity charOffset="124-136" id="DDI-PubMed.28851254.s5.e1" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.28851254.s5.e0" e2="DDI-PubMed.28851254.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28851254.s5.e0" e2="DDI-PubMed.28851254.s5.e1" /></sentence><sentence text="0 and 13" /><sentence text="0, indicating that ketoconazole accumulates in liver"><entity charOffset="19-31" id="DDI-PubMed.28851254.s7.e0" text="ketoconazole" /></sentence><sentence text=" The ratios of inhibition constants in rat liver microsomes (Ki,mic,u) to that in rat cryopreserved hepatocytes (Ki,hep,u) for fluconazole and ketoconazole were 1"><entity charOffset="127-138" id="DDI-PubMed.28851254.s8.e0" text="fluconazole" /><entity charOffset="143-155" id="DDI-PubMed.28851254.s8.e1" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.28851254.s8.e0" e2="DDI-PubMed.28851254.s8.e0" /><pair ddi="false" e1="DDI-PubMed.28851254.s8.e0" e2="DDI-PubMed.28851254.s8.e1" /></sentence><sentence text="5 and 25" /><sentence text="5, which were similar to the Kp,uu and suggested that cryopreserved hepatocytes could mimic the hepatic accumulation of inhibitors" /><sentence text=" 3" /><sentence text=" The increases in AUC of nifedipine predicted by the minimal PBPK model using [I]liver,u/Ki,mic,u and [I]sys,u/Ki,hep,u were within 1"><entity charOffset="25-35" id="DDI-PubMed.28851254.s12.e0" text="nifedipine" /></sentence><sentence text="5-fold of the observed values for both inhibitors, whereas the model using [I]sys,u/Ki,mic,u underestimated the AUC increase caused by ketoconazole 21-fold" /><sentence text=" 4" /><sentence text=" These results indicated that hepatic accumulation factor of an inhibitor is required for a precise DDI projection and that cryopreserved hepatocytes would be useful to obtain the Ki including hepatic accumulation factor" /><sentence text=" It was demonstrated that PBPK model using Ki,hep,u could be a valuable approach for quantitative DDI projection" /><sentence text="" /></document>